Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.

Cancer Cytopathol 2012 Aug 20;120(4):230-7. Epub 2012 Mar 20.

Department of Pathology, Stanford University, Stanford, California 94305, USA.

Background: Distinguishing hepatocellular carcinoma (HCC) from adenocarcinoma in fine-needle aspiration biopsies (FNAB) is often diagnostically challenging. Arginase-1 was recently described as a marker of hepatic differentiation in surgical resection specimens. We compared the expression of arginase-1, HepPar-1, and glypican-3 in FNAB of HCC and adenocarcinoma involving the liver.

Methods: Ninety-eight FNABs including 37 primary or metastatic HCCs (30 well or moderately differentiated and 7 poorly differentiated) and 61 adenocarcinomas involving the liver were evaluated for immunohistochemical expression of arginase-1, HepPar-1, and glypican-3 using formalin-fixed paraffin-embedded cell block material.

Results: Arginase-1 was more sensitive (81%) than HepPar-1 (70%) or glypican-3 (54%) for HCC. Arginase-1 more often demonstrated diffuse staining, defined as reactivity in >50% of the tumor, in HCC (21 of 37; 57%) compared with HepPar-1 (15 of 37; 41%) and glypican-3 (12 of 37; 32%). Of the 7 poorly differentiated HCCs, 3 (43%) were immunoreactive for both arginase-1 and glypican-3, whereas only 1 (14%) demonstrated HepPar-1 staining. Arginase-1 expression was identified in adenocarcinomas of pancreatic, colorectal, and breast origin, and reactivity was diffuse in 2 pancreatic adenocarcinomas (2 of 15; 13%).

Conclusions: Arginase-1 is a more sensitive marker of hepatic differentiation than either HepPar-1 or glypican-3 in FNAB. In addition, arginase-1 exhibits more diffuse staining in HCC than either HepPar-1 or glypican-3, making interpretation easier in limited FNAB samples. Arginase-1 is not entirely specific for hepatic differentiation, as immunoreactivity can be identified in adenocarcinomas, particularly of pancreatic origin.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21190DOI Listing
August 2012
8 Reads

Publication Analysis

Top Keywords

heppar-1 glypican-3
20
hepatic differentiation
16
arginase-1 sensitive
12
marker hepatic
12
arginase-1
11
hcc adenocarcinoma
8
aspiration biopsies
8
adenocarcinomas pancreatic
8
arginase-1 heppar-1
8
diffuse staining
8
glypican-3 fnab
8
fine-needle aspiration
8
expression arginase-1
8
identified adenocarcinomas
8
differentiation heppar-1
8
heppar-1
8
glypican-3
8
sensitive marker
8
hcc
5
formalin-fixed paraffin-embedded
4

Altmetric Statistics

References

(Supplied by CrossRef)
Hepatocellular carcinoma
El-Serag et al.
N Engl J Med. 2011
Diagnosis of hepatocellular carcinoma
Gomaa et al.
World J Gastroenterol. 2009
Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms
Kakar et al.
Arch Pathol Lab Med. 2007

Similar Publications